Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shin Nippon Biomedical Laboratories (SNBL) is a Japanese Contract Research Organization (CRO) founded in 1957. It specializes in preclinical studies, especially primate testing, and translational research. SNBL operates across global and Japanese markets, providing services in CRO, Translational Research, and health promotion (e.g., proton therapy). The company is known for its expertise in non-clinical trials and has established key partnerships and academic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shin Nippon Biomedical Research Institute.